SMS Pharmaceuticals Flags 85,000 Shares Fraudulent Claim

SMS Pharmaceuticals Ltd has uncovered a fraudulent scheme involving the impersonation of shareholders to claim 85,000 equity shares held in physical form. The company's investigation revealed forged KYC documents and a consistent modus operandi used to fraudulently transfer shares belonging to seven original shareholders. Following the advice of its Stakeholders Relationship Committee, the company has filed a complaint with the Economic Offences Wing (EOW) in Hyderabad, which has registered a case for further investigation. SMS Pharmaceuticals is committed to protecting shareholder interests and will pursue all necessary legal and regulatory actions.